Investors

List of the current and past investors into Cylene Pharmaceuticals Inc with their respective financial instruments.

Profile Country Phone Round
BioVentures Investors LLC United States +1 (617) 252-3443 Series D
BioVentures Investors LLC United States +1 (617) 252-3443 Series B
BioVentures Investors LLC United States +1 (617) 252-3443 Series C
Celgene Corp Biopharmaceutical company committed to improving the lives of patients worldwide. United States Series C
Coastview Capital LLC United States Series B
HBM BioVentures AG Switzerland +41 (41) 768-1108 Series D
HBM BioVentures AG Switzerland +41 (41) 768-1108 Series C
IngleWood Ventures United States +1 (858) 792-3579 Series A
Lilly Ventures United States +1 (317) 651-3050 Series C
Lilly Ventures United States +1 (317) 651-3050 Series D
Mitsui & Co Global Investment Inc (三井グループ) United States Series C
Mitsui & Co Global Investment Inc (三井グループ) United States Series D
Mitsui & Co Global Investment Ltd (MCVP) Japan +86 (21) 5298-5959 Series B
Morningside Group China +852 2894-9800 Series B
Morningside Group China +852 2894-9800 Series D
Novartis Services Inc (Novartis Venture Fund) United States +1 (617) 871-3536 N/A
Novartis Services Inc (Novartis Venture Fund) United States +41 (61) 324-3714 N/A
Novartis Venture Funds The corporate venturing arm of Novartis. Switzerland +41 (61) 324-6210 Series C
Novartis Venture Funds The corporate venturing arm of Novartis. Switzerland +41 (61) 324-6210 Series D
RCT BioVentures (Research Corporation Technologies BioVentures) The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies United States +1 (310) 824-1700 N/A
RCT BioVentures (Research Corporation Technologies BioVentures) The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies United States +1 (310) 824-1700 Series C
RCT BioVentures (Research Corporation Technologies BioVentures) The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies United States +1 (310) 824-1700 Series A
Sanderling Ventures United States +1 (650) 401-2000 Series C